| dc.contributor.advisor | Barun Kumar Roy | en_US |
| dc.contributor.author | Islam, Sumaiya | |
| dc.date.accessioned | 2026-08-24T10:07:01Z | |
| dc.date.available | 2026-08-24T10:07:01Z | |
| dc.date.issued | 2026-04-21 | |
| dc.identifier.other | ID 2120432 | |
| dc.identifier.uri | https://ar.iub.edu.bd/handle/11348/1550 | |
| dc.description | This in plant training report submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy from the Department of Pharmacy, 2026. | en_US |
| dc.description.abstract | Eskayefs manufacturing facility has transcended the frontiers after the accreditation of UK MHRA (United Kingdom Medicines and Healthcare products Regulatory Agency). Eskayef has been growing rnore globally since 2005 and exporting bulk pellets and
finished products in Asi4 Africa, Central America, Europ and Australia. The company is also tied up with the world leader in eye care solution Allergan Inc. Ireland. The company often manufactures insulin in a world clr.cs facility which is being exported to
Novo Nordisk. | en_US |
| dc.format.extent | 59 pages | |
| dc.language.iso | en | en_US |
| dc.publisher | Independent University, Bangladesh (IUB) | en_US |
| dc.rights | Theses submitted to Independent University, Bangladesh are protected by copyright. They may be accessed for academic and research purposes; however, reproduction, distribution, or use of the material in any form requires prior written permission from the University. | |
| dc.subject | SK+F | en_US |
| dc.subject | Pharmaceutical industries -- Bangladesh | en_US |
| dc.subject | Pharmaceutical Manufacturing -- Quality Control | en_US |
| dc.title | Eskayef Pharmaceuticals Limited in plant training report | en_US |
| dc.type | In plant Training Report | en_US |
| dc.contributor.department | Department of Pharmacy | |
